IMS-3, SYNTHESIS, and MR RESCUE: No disaster, but down to earth

Clinical Neuroradiology

Volumn 23, Issue 1, 2013, Pages 1-3

  Von Kummer, Rüdiger ^a   Gerber, Johannes ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTERY OCCLUSION; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DIFFUSION WEIGHTED IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EMBOLECTOMY; HEART INFARCTION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE CEREBRAL ARTERY OCCLUSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; RECANALIZATION; RISK REDUCTION; THROMBECTOMY; TREATMENT OUTCOME;

ENDOVASCULAR PROCEDURES; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84874365640     PISSN: 18691439     EISSN: 18691447     Source Type: Journal    
DOI: 10.1007/s00062-013-0214-1     Document Type: Editorial

References (13)

1. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-7.
2. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-29.
3. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-703.
4. Kassem-Moussa H, Graffagnino C. Non-arterial occlusion at different time-points after stroke onset. Arch Neurol. 2002;59:1870-3.
5. von Kummer R, Bourquain H, Bastianello S, Bozzao L, Manelfe C, Meier D, Hacke W, for the ECASS II Group. Early prediction of irreversible brain damage after ischemic stroke by computed tomography. Radiology. 2001;219:95-100.
6. Shobha N, Bhatia R, Boyko M, Tymchuk S, Kumarpillai G, Smith E, Demchuk AM. Outcomes in acute ischemic stroke presenting with disabling neurological deficits without intracranial vascular occlusion. Int J Stroke. 2011;6:392-7.
7. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F, for the PROACT investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-11.
8. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter S, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ Janis LS, Martin RL, Foster LD, Tomsick TA, for the IMS III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for Stroke. N Eng J Med. 2013, doi:10.1056/NEJMoa1214300 (published online on February 7, 2013).
9. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, Boccardi E, for the SYNTHESIS Expansion Inverstigators. Endovascular treatment for acute ischemic stroke. N Eng J Med. 2013. doi:10.1056/NEJMoa1213701 (published online on February 6, 2013).
10. Kidwell CS, Jahan R, Gornbei J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL, for the MR RESCUE investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013. doi:10.1056/NEJMoa1212793 (published online on February 8, 2013).
11. Brinjikji W, Rabinstein AA, Kallmes DF, Cloft HJ. Patients' outcome with endovascular embolectomy therapy for acute ischemic stroke: a study of the national inpatient sample: 2006 to 2008. Stroke. 2011;42:1648-52.
12. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA, IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73:1066-72.
13. von Kummer R, Albers GW, Mori E, on behalf of the DIAS Steering Committees. The Desmoteplase in Acute Ischaemic Stroke (DIAS) clinical trial programme. Int J Stroke. 2012;7:589-96.